---
schema_version: "secwatch.filing_event.v1"
accession: "0001104659-23-038395"
form_type: "8-K"
ticker: null
cik: "0001173281"
company_name: "NeuBase Therapeutics, Inc."
filed_at: "2023-03-29T23:59:59+00:00"
generated_at: "2026-06-17T09:59:16.041899+00:00"
event_type: "regulatory"
sentiment: "negative"
materiality_score: 0.65
calibrated_materiality_score: 0.65
confidence: "high"
source: SEC EDGAR
---

# NeuBase receives Nasdaq notice of additional 180-day compliance period for bid price deficiency

## Summary
- Nasdaq granted NeuBase until September 25, 2023 to regain minimum bid price of $1.00 per share.
- Company failed to meet minimum bid price requirement by initial deadline of March 28, 2023.
- Company intends to consider options including reverse stock split to regain compliance.
- If not compliant by September 25, 2023, Nasdaq will delist; company may appeal.
- Stock continues trading on Nasdaq Capital Market during additional period.

## SEC filing metadata
- accession: 0001104659-23-038395
- form_type: 8-K
- cik: 0001173281
- company_name: NeuBase Therapeutics, Inc.
- filed_at: 2023-03-29T23:59:59+00:00
- event_type: regulatory
- sentiment: negative
- materiality_score: 0.65
- calibrated_materiality_score: 0.65
- confidence: high
- sec_items: 3.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1173281/000110465923038395/0001104659-23-038395-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1173281/000110465923038395/tm2310937d1_8k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001104659-23-038395
- JSON: https://secwatch.observer/filing/0001104659-23-038395.json
- Plain text: https://secwatch.observer/filing/0001104659-23-038395.txt

## Key facts
- Listing & Compliance Notices
  NeuBase Therapeutics, Inc. received a nasdaq extension granted notice regarding minimum bid price (rules 5550(a)(2), 5810(c)(3)(A)).
  - Exchange: nasdaq
  - Notice: extension granted
  - Deficiency: minimum bid price
  - Rules: 5550(a)(2), 5810(c)(3)(A)
  source text: March 29, 2023, Nasdaq notified the Company in writing that while the Company had not regained compliance with the Minimum Bid Price Requirement, it was eligible for an additional 180 calendar day period, or until September 25, 2023, to regain compliance with the Minimum Bid Price Requirement. Nasdaq’s determination was based on the Company having met the continued listing requirement for market value of publicly held shares and all other applicable requirements for initial listing on The Nasdaq Capital Market, with the exception of the Minimum Bid Price Requirement, and on the Company’s writt
  evidence_url: https://www.sec.gov/Archives/edgar/data/1173281/000110465923038395/0001104659-23-038395-index.htm

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.